SYNTHESIS & STUDY OF HISTAMINE H2 RECEPTOR ANTAGONISTS
合成
基本信息
- 批准号:3438512
- 负责人:
- 金额:$ 7.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-09-01 至 1989-05-31
- 项目状态:已结题
- 来源:
- 关键词:X ray crystallography antiarrhythmic agent antihistamines chemical binding conformation dosage drug design /synthesis /production drug interactions drug metabolism gastric acid gastric juice inhibitor gastric mucosa gastrointestinal pharmacology heart pharmacology myocardium smooth muscle spectrometry
项目摘要
Our purpose is to more fully understand the geometrical requirements of the
histamine H2-receptor antagonists and the H2-receptor site. Specifically,
syntheses of macrocyclic analogues of H2-receptor antagonists would be
pursued. Such compounds would be locked into cis folded conformations and
would provide insight into the nature of the interaction of antagonists
with the H2-receptor site as assessed from biological data. The efficacy
of these compounds as H2-receptor antagonists would be ascertained by
pharmacologic protocols involving H2-specific tissues such as gastric
mucosa, guinea pig right atrium, and rat uterus. Relative binding
affinities (pA2) will be calculated from dose-response curves exhibiting
competitive antagonism of histamine H2 sites by the synthesized compounds.
Conformational analyses of these macrocyclic compounds would be studied by
the use of molecular mechanics and molecular orbital techniques as well as
spectroscopic and crystallographic methods. The pharmacological actions of
histamine are considered to be mediated by at least two distinct classes of
receptor, designated H1 and H2, distinguished by the action of specific
histamine antagonists that selectively block histamine responses.
Histamine evidently plays an important role on the gastric mucosa, smooth
muscle, myocardium, adrenal medulla, and certain neural processes, and may
involve cyclic AMP as a second messenger in these pharmacological actions.
Histamine H2-receptor antagonists are widely used as effective inhibitors
of gastric acid secretion in the treatment of duodenal ulcers and related
conditions. Histamine receptors are also important in controlling heart
rate. It appears as if H2 receptors are responsible for mediating
histamine-induced idioventricular tachyarrhythmia. This may have important
implications for the treatment of ventricular arrhythmia caused by
histamine release. At present, the geometrical requirements of histamine
H2-receptor antagonists are ambiguous. Neither the binding site geometry
nor the requirements for efficient absorption of the antagonists are
understood. Macrocyclic analogues of histamine H2-receptor antagonists
would be useful in understanding the nature of interaction of antagonists
with H2-receptor sites, and would provide additional information as to the
geometrical and conformational requirements of these drugs. Apparent
conformation-relative binding affinity relationships should provide insight
for further histamine H2-receptor investigations.
我们的目的是更充分了解
组胺H2受体拮抗剂和H2受体位点。 具体来说,
H2受体拮抗剂的大环类似物的合成将是
追捕。 这样的化合物将锁定为顺式折叠构象和
将洞悉拮抗剂相互作用的性质
从生物学数据中评估的H2受体位点。 功效
这些化合物中的H2受体拮抗剂将通过
涉及H2特异性组织(例如胃)的药理方案
粘膜,豚鼠右心房和大鼠子宫。 相对结合
亲和力(PA2)将根据表现出的剂量反应曲线计算
组胺H2位点的竞争性拮抗作用是合成化合物的。
这些大环化合物的构象分析将通过
分子力学和分子轨道技术的使用以及
光谱和晶体学方法。 的药理作用
组胺被认为是由至少两个不同的类别介导的
受体,指定为H1和H2,以特定的作用为特殊
组胺拮抗剂有选择地阻断组胺反应。
组胺显然在胃粘膜上起重要作用,光滑
肌肉,心肌,肾上腺髓质和某些神经过程,可能
在这些药理作用中涉及循环放大器作为第二信使。
组胺H2受体拮抗剂被广泛用作有效抑制剂
胃酸分泌在十二指肠溃疡和相关的治疗中
状况。 组胺受体对于控制心脏也很重要
速度。 似乎H2受体负责介导
组胺引起的愚蠢心律失常。 这可能很重要
对治疗心室心律不齐的影响
组胺释放。 目前,组胺的几何需求
H2受体拮抗剂是模棱两可的。 绑定位点几何形状都不
对拮抗剂有效吸收的要求也不是
理解。 组胺H2受体拮抗剂的大环类似物
将有助于理解拮抗剂相互作用的性质
使用H2受体站点,并将提供有关
这些药物的几何和构象要求。 显而易见
构象相关的结合亲和力关系应提供洞察力
用于进一步的组胺H2受体研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM N SETZER其他文献
WILLIAM N SETZER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM N SETZER', 18)}}的其他基金
Anti-Trypanosomal Agents from a Neotropical Cloudforest
来自新热带云林的抗锥虫药物
- 批准号:
6751125 - 财政年份:2004
- 资助金额:
$ 7.08万 - 项目类别:
MEDICINAL AGENTS FROM TROPICAL AUSTRALIAN PLANTS
来自澳大利亚热带植物的药用成分
- 批准号:
2076765 - 财政年份:1996
- 资助金额:
$ 7.08万 - 项目类别:
相似国自然基金
延迟整流钾通道IKr和IKs双重阻滞剂的合理药物设计、合成与药效学评价研究
- 批准号:30901836
- 批准年份:2009
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Regulation of HERG proteins by chemical chaperones
化学伴侣对 HERG 蛋白的调节
- 批准号:
6552083 - 财政年份:2002
- 资助金额:
$ 7.08万 - 项目类别:
Regulation of HERG proteins by chemical chaperones
化学伴侣对 HERG 蛋白的调节
- 批准号:
6619673 - 财政年份:2002
- 资助金额:
$ 7.08万 - 项目类别:
Regulation of HERG proteins by chemical chaperones
化学伴侣对 HERG 蛋白的调节
- 批准号:
6783338 - 财政年份:2002
- 资助金额:
$ 7.08万 - 项目类别:
CLINICAL PHARMACOLOGY OF POTASSIUM CHANNEL MODULATORS
钾通道调节剂的临床药理学
- 批准号:
3756343 - 财政年份:
- 资助金额:
$ 7.08万 - 项目类别:
CLINICAL PHARMACOLOGY OF POTASSIUM CHANNEL MODULATORS
钾通道调节剂的临床药理学
- 批准号:
3734764 - 财政年份:
- 资助金额:
$ 7.08万 - 项目类别: